Vivani was created in 2022 when subdermal drug implant company Nano Precision Medical merged with implantable visual ...

Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing ...

Vivani Medical, Inc. (NASDAQ:VANI) said it intends to spin off Cortigent, Inc., a division that develops brain implant ...

Vivani Medical (VANI) announced that it intends to spin off Cortigent, a division that develops brain implant devices to help people recover ...

The company wants to create two focused companies dedicated to driving current and future value in their respective ...

The Vivani Medical Inc. combination appears to be over less than three years since its inception after the company reported ...

Vivani Medical completed enrollment in its LIBERATE-1 trial, testing a six-month GLP-1 implant for weight management.

Vivani Medical, Inc. (NASDAQ: VANI), a biopharmaceutical company with a market capitalization of $62.2 million, has announced its intention to spin off Cortigent, Inc., its division focused on ...

Cortigent is a precision neurostimulation technology that seeks to provide an artificial vision for blind people. Jonathan Adams has served as Cortigent's CEO since 2023 and will retain that ...

Cortigent’s Orion® artificial vision system, which is in development to treat blindness, completed an initial 6-year clinical study in 2024, with encouraging safety and efficacy results ...